← Leaderboards
Murray B Resnick
Rhode Island Hospital
$1,228,803
Attributed
$1,228,803
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $289.8K · FY2015–19$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,228,803 · 1
By mechanism
P30$1,228,803 · 1
Top collaborators
No co-investigators on record.
Most similar at Rhode Island Hospital
Same institution · by research overlap
- Qian Chen$25,602,425
- Marina Tolou-Shams$14,077,192
- Roland C Merchant$12,559,068
- Christopher D. Houck$9,708,192
- Patrycja Marta Dubielecka-Szczerba$3,859,763
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMeetingsLifeLettersBudgetsBioinformaticsInterestCancerousInvestmentsBiological SciencesCommunitiesConsultationsData AnalysesExperimental DesignsExtramural ActivitiesFacultyFundingGrantCenters Of Research ExcellenceHospitalsImageIndustryInstitutionMentors
Grant awards (5)
COBRE Center for Cancer Research Development$204,192
P30 · FY2019 · GM · contact PI
COBRE Center for Cancer Research Development$219,680
P30 · FY2018 · GM · contact PI
COBRE Center for Cancer Research Development$246,773
P30 · FY2017 · GM · contact PI
COBRE Center for Cancer Research Development$268,358
P30 · FY2016 · GM · contact PI
COBRE Center for Cancer Research Development$289,800
P30 · FY2015 · GM · contact PI